Search results
Results From The WOW.Com Content Network
Saxenda® is an injectable medicine used for adults with excess weight who may also have weight-related medical problems or obesity and children aged 12-17 years with a body weight above 132 pounds and obesity. Read Important Safety and Prescribing Info, including Boxed Warning.
Saxenda® is an FDA-approved weight-loss medicine that can help you lose weight and keep it off. Read Important Safety and Prescribing Info, including Boxed Warning.
Find week-by-week dosing schedules for your Saxenda® pen. Discover the correct dosage for you today. Read Important Safety and Prescribing Info, including Boxed Warning.
Learn about potential side effects of treatment with Saxenda® when using the Saxenda® pen. Read Important Safety and Prescribing Info, including Boxed Warning.
Saxenda ® (liraglutide) injection 3 mg is an injectable prescription medicine used for adults with excess weight (BMI ≥27) who also have weight-related medical problems or obesity (BMI ≥30), and children aged 12-17 years with a body weight above 132 pounds (60 kg) and obesity to help them lose weight and keep the weight off.
Learn how to use the Saxenda® pen, including how to attach a new needle, selecting a specific dosage, and more today. Read Important Safety and Prescribing Info, including Boxed Warning.
Get answers to all of your questions regarding the Saxenda® pen and how it works. Read important safety information on this page.
Explore prescription coverage options to save on your Saxenda® prescription. Find coupons and other savings. Read Important Safety and Prescribing Info, including Boxed Warning.
Saxenda® (liraglutide) injection 3 mg is an injectable prescription medicine that may help some adults with excess weight (BMI ≥27) who also have weight-related medical problems or obesity (BMI ≥30) lose weight and keep the weight off.
What is Saxenda ®? Saxenda ® (liraglutide) injection 3 mg is an injectable prescription medicine used for adults with excess weight (BMI ≥27) who also have weight-related medical problems or obesity (BMI ≥30), and children aged 12-17 years with a body weight above 132 pounds (60 kg) and obesity to help them lose weight and keep the weight ...